Literature DB >> 11435176

Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.

S Shintani1, Y Nakahara, M Mihara, Y Ueyama, T Matsumura.   

Abstract

The p14(ARF), p15(INK4B) and p16(INK4A) genes were localized to 9p21, where genetic alterations have been reported frequently in various human tumors. We performed a molecular analysis of the mechanism of inactivation in cell lines and 32 oral squamous cell carcinoma (OSCC), using deletion screening, PCR-SSCP, methylation-specific-PCR and cycle sequencing. We detected homozygous deletion of p14(ARF)-1Ebeta in 9 (26.5%), of p15(INK4B) in one (3.1%), and of p16(INK4A) in 22 (56.3%) tumor samples. Three mutations were detected in the p16(INK4A) genes. We detected aberrant methylation of the p14(ARF) genes in 14 (43.8%), of the p15(INK4B) gene in 9 (28.1%), and of the p16(INK4A) gene in 16 (50.0%) tumor samples. Altogether, 87.5% of the samples harbored at least one of the alterations in the p14(ARF), p15(INK4B), and p16(INK4A) genes, indicating that the frequent inactivation of these genes may be an important mechanism during OSCC development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435176     DOI: 10.1016/s1368-8375(00)00142-1

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  29 in total

1.  Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.

Authors:  Keizo Kato; Akira Hara; Toshiya Kuno; Hideki Mori; Tomomi Yamashita; Makoto Toida; Toshiyuki Shibata
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-22       Impact factor: 4.553

2.  DNA hypermethylation profiles in squamous cell carcinoma of the vulva.

Authors:  Josena K Stephen; Kang Mei Chen; Misa Raitanen; Seija Grénman; Maria J Worsham
Journal:  Int J Gynecol Pathol       Date:  2009-01       Impact factor: 2.762

3.  Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

Authors:  Jacqueline A Gasche; Jürgen Hoffmann; C Richard Boland; Ajay Goel
Journal:  Int J Cancer       Date:  2011-01-07       Impact factor: 7.396

Review 4.  Delineating an epigenetic continuum in head and neck cancer.

Authors:  Maria J Worsham; Josena K Stephen; Kang Mei Chen; Shaleta Havard; Veena Shah; Glendon Gardner; Vanessa G Schweitzer
Journal:  Cancer Lett       Date:  2012-03-01       Impact factor: 8.679

5.  Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis.

Authors:  Maureen A Sartor; Dana C Dolinoy; Tamara R Jones; Justin A Colacino; Mark E P Prince; Thomas E Carey; Laura S Rozek
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

6.  Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells.

Authors:  Yen-Ting Liu; Lin Xu; Lynda Bennett; Jared C Hooks; Jing Liu; Qinbo Zhou; Priscilla Liem; Yanbin Zheng; Stephen X Skapek
Journal:  Mol Cancer Res       Date:  2019-06-12       Impact factor: 5.852

7.  Small biopsy specimens reliably indicate p16 expression status of oropharyngeal squamous cell carcinoma.

Authors:  Changqing Ma; James Lewis
Journal:  Head Neck Pathol       Date:  2011-12-28

8.  Consistent DNA hypermethylation patterns in laryngeal papillomas.

Authors:  Josena K Stephen; Kang Mei Chen; Veena Shah; Vanessa G Schweitzer; Glendon Gardner; Michael S Benninger; Maria J Worsham
Journal:  Int J Head Neck Surg       Date:  2010-05

9.  Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients.

Authors:  Katarzyna Kiwerska; Małgorzata Rydzanicz; Andrzej Kram; Martyna Pastok; Agata Antkowiak; Wenancjusz Domagała; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

10.  Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Authors:  Emanuela Taioli; Camille Ragin; Xiao-Hong Wang; Jiangying Chen; Scott M Langevin; Ashley R Brown; Susanne M Gollin; Seymour Garte; Robert W Sobol
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.